Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Uetake

Showing results (71-80 of 206) with videos related to

Pageof 21
Sort By:
BMC Clinical Pathology|May 4, 2017
High expression of EphA3 (erythropoietin-producing hepatocellular A3) in gastric cancer is associated with metastasis and poor survivalBaongoc Nasri, Mikito Inokuchi, Toshiaki Ishikawa, et al.
International Journal of Oncology|April 8, 2010
Clinicopathological and prognostic significance of PDCD4 and microRNA-21 in human gastric cancerKazuo Motoyama, Hiroshi Inoue, Koshi Mimori, et al.
Surgery Today|August 20, 2013
Intra-abdominal desmoid tumor difficult to distinguish from a gastrointestinal stromal tumor: report of two casesNorihito Ogawa, Hideaki Iseki, Hidefumi Tsunozaki, et al.
Diseases of the Colon and Rectum|February 14, 2006
Coexpression of VEGF-C and Cox-2 in human colorectal cancer and its association with lymph node metastasisLabile Togba Soumaoro, Hiroyuki Uetake, Yoko Takagi, et al.
Annals of Surgical Oncology|November 14, 2014
Erythropoietin-Producing Hepatocellular A1 is an Independent Prognostic Factor for Gastric CancerMasatoshi Nakagawa, Mikito Inokuchi, Yoko Takagi, et al.
International Journal of Clinical Oncology|January 7, 2019
mFOLFOX6 plus bevacizumab to treat liver-only metastases of colorectal cancer that are unsuitable for upfront resection (TRICC0808): a multicenter phase II trial comprising the final analysis for survivalMasamichi Yasuno, Hiroyuki Uetake, Megumi Ishiguro, et al.
Oncology Reports|December 22, 2007
Decreased expression of SOCS-3 mRNA in breast cancer with lymph node metastasisTsuyoshi Nakagawa, Satoru Iida, Takayuki Osanai, et al.
Japanese Journal of Clinical Oncology|May 10, 2013
KRAS mutational status in Japanese patients with colorectal cancer: results from a nationwide, multicenter, cross-sectional studyToshiaki Watanabe, Takayuki Yoshino, Hiroyuki Uetake, et al.
International Journal of Cancer|June 26, 2007
PIK3CA mutation is predictive of poor survival in patients with colorectal cancerShunsuke Kato, Satoru Iida, Tetsuro Higuchi, et al.
International Journal of Cancer|February 18, 2010
MUC12 mRNA expression is an independent marker of prognosis in stage II and stage III colorectal cancerTakatoshi Matsuyama, Toshiaki Ishikawa, Kaoru Mogushi, et al.
Pageof 21

Showing results (71-80 of 206) with videos related to

Sort By:
Pageof 21
BMC Clinical Pathology|May 4, 2017
High expression of EphA3 (erythropoietin-producing hepatocellular A3) in gastric cancer is associated with metastasis and poor survivalBaongoc Nasri, Mikito Inokuchi, Toshiaki Ishikawa, et al.
International Journal of Oncology|April 8, 2010
Clinicopathological and prognostic significance of PDCD4 and microRNA-21 in human gastric cancerKazuo Motoyama, Hiroshi Inoue, Koshi Mimori, et al.
Surgery Today|August 20, 2013
Intra-abdominal desmoid tumor difficult to distinguish from a gastrointestinal stromal tumor: report of two casesNorihito Ogawa, Hideaki Iseki, Hidefumi Tsunozaki, et al.
Diseases of the Colon and Rectum|February 14, 2006
Coexpression of VEGF-C and Cox-2 in human colorectal cancer and its association with lymph node metastasisLabile Togba Soumaoro, Hiroyuki Uetake, Yoko Takagi, et al.
Annals of Surgical Oncology|November 14, 2014
Erythropoietin-Producing Hepatocellular A1 is an Independent Prognostic Factor for Gastric CancerMasatoshi Nakagawa, Mikito Inokuchi, Yoko Takagi, et al.
International Journal of Clinical Oncology|January 7, 2019
mFOLFOX6 plus bevacizumab to treat liver-only metastases of colorectal cancer that are unsuitable for upfront resection (TRICC0808): a multicenter phase II trial comprising the final analysis for survivalMasamichi Yasuno, Hiroyuki Uetake, Megumi Ishiguro, et al.
Oncology Reports|December 22, 2007
Decreased expression of SOCS-3 mRNA in breast cancer with lymph node metastasisTsuyoshi Nakagawa, Satoru Iida, Takayuki Osanai, et al.
Japanese Journal of Clinical Oncology|May 10, 2013
KRAS mutational status in Japanese patients with colorectal cancer: results from a nationwide, multicenter, cross-sectional studyToshiaki Watanabe, Takayuki Yoshino, Hiroyuki Uetake, et al.
International Journal of Cancer|June 26, 2007
PIK3CA mutation is predictive of poor survival in patients with colorectal cancerShunsuke Kato, Satoru Iida, Tetsuro Higuchi, et al.
International Journal of Cancer|February 18, 2010
MUC12 mRNA expression is an independent marker of prognosis in stage II and stage III colorectal cancerTakatoshi Matsuyama, Toshiaki Ishikawa, Kaoru Mogushi, et al.
Pageof 21